beauty

Aptar Pharma Multidose Device Delivers Approved Human Monoclonal Antibody Anti-COVID Nasal Spray in Thailand

prpackagingcon…
December
21
/ 2022

Tags

Crystal Lake, Illinois, December 20, 2022 - Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, today announced that its VP7 nasal multidose device is the delivery system for Hibiocy’s VAILL COVITRAP™ Anti-CoV nasal spray, which was recently approved by the Thailand Food and Drug Administration (FDA).

/
Aptar Mumbai Celebrates 10 Year Anniversary and Announces Construction of New Facility
Continue reading
/
Neopac’s Polyfoil MMB® Tube Approved by RecyClass Recycling Standards Association
Continue reading
/
,
Neopac Wins European Tube Manufacturers Association Awards in Laminates, Prototypes Categories
Continue reading
/
Aptar Pharma Enters into Partnership with Stallergenes Greer to Develop Novel Digital Health Ecosystem for Allergen Immunotherapy Treatment
Continue reading
/
Aptar Pharma and i2c Pharmaceutical Services Announce Partnership for Next Generation Propellant Dispersible Tablet pMDI Technology
Continue reading
/
Preferred by Home Delivery Consumers, Aptar Food + Beverage’s SeaWell™ Active Packaging Systems Passes ISTA and ASTM Testing
Continue reading
/
WWP Beauty Launches Two New Collections Focused on Blue Light Protection and At-Home Beauty Rituals
Continue reading
/
Aptar Declares Quarterly Dividend and Announces 2021 Annual Meeting Details
Continue reading
/
Covid-19 Foresight 2020 Research Programme by Aptar Beauty + Home over 4000 consumers and 4 key geographies
Continue reading
/
,
Unilever Launches Its Largest Refill Trial in Europe
Continue reading
Subscribe to beauty